Sign in
APEN Stock Price, Chart, Stats & News
Apollo Endosurgery, Inc.
Save
579.72M
Market cap
–
Current P/E
–
Forward P/E
APEN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 55.20% |
Operating margin | -36.20% |
Pretax margin | -51.08% |
Net margin | -51.84% |
Effective tax rate | -1.49% |
ROA | -36.14% |
ROE | -84.92% |
D/E | 1.75x |
Interest coverage ratio | -5.96x |
APEN valuation
P/E | – |
P/S | 7.54x |
P/B | 12.47x |
P/CF | -13.00x |
P/FCF | -17.05x |
P/OCF | -13.00x |
PEG | -0.10x |
EV multiple | -18.45x |
About
Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System.
Similar securities
Based on sector and market capitalization
Report issue